Athena Countouriotis Insider Trading $GYHT HALOZYME THERAPEUTICS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Athena Countouriotis.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Athena Countouriotis. Athena Countouriotis is SVP and Chief Medical Officer in HALOZYME THERAPEUTICS INC ($GYHT) and Chief Medical Officer in AMBIT BIOSCIENCES CORP ($AMBI) and Director in Trovagene, Inc. ($XNOM.OB) and Director in IOVANCE BIOTHERAPEUTICS, INC. ($IOVA) and SVP, Chief Medical Officer in Adverum Biotechnologies, Inc. ($ADVM) and President & CEO in Turning Point Therapeutics, Inc. ($TPTX) and Director in Passage BIO, Inc. ($PASG).

Athena Countouriotis in HALOZYME THERAPEUTICS, INC.

Trading Symbol: GYHT
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Athena Countouriotis: SVP and Chief Medical Officer
Holdings: 45,977 shares
Latest Transaction: Feb 06 2017

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Athena Countouriotis in HALOZYME THERAPEUTICS, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ADVM, AMBI, XNOM.OB, GYHT, IOVA, PASG, TPTX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 06 2017GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...Option ExerciseM0.0018,496055,487
Feb 06 2017GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...Payment of ExerciseF12.266,90084,59439,07746 K to 39.1 K (-15.01 %)
Feb 06 2017GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...BuyM0.0018,496045,97727.5 K to 46 K (+67.30 %)
Jan 09 2017GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...Option ExerciseM0.007,500015,000
Jan 09 2017GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...BuyM0.007,500027,48120 K to 27.5 K (+37.54 %)
Jul 05 2016GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...Option ExerciseM0.006,45000
Jul 05 2016GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...Option ExerciseA0.006,45006,450
Jul 05 2016GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...Payment of ExerciseF8.6310792319,98120.1 K to 20 K (-0.53 %)
Jul 05 2016GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...BuyM0.006,450020,08813.6 K to 20.1 K (+47.29 %)
Feb 04 2016GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...Option ExerciseA0.0073,983073,983
Feb 04 2016GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...Option ExerciseA8.11125,5231,017,992125,523
Jan 07 2016GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...Option ExerciseM0.007,500022,500
Jan 07 2016GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...Payment of ExerciseF16.393,25753,38213,63816.9 K to 13.6 K (-19.28 %)
Jan 07 2016GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...BuyM0.007,500016,8959.4 K to 16.9 K (+79.83 %)
Jan 04 2016GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...Payment of ExerciseF17.335,65598,0019,39515.1 K to 9.4 K (-37.57 %)
Jan 04 2016GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...GrantA0.0015,050015,0500 to 15.1 K

Page:   1